COMP

Compass, Inc.'s (NYSE:COMP) strong earnings report was rewarded with a positive stock price move. Our analysis found some more factors that we think are good for shareholders. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. One essential aspect of assessing earnings quality is to look at how much a company is diluting shareholders. In fact, Compass increased the number of shares on issue by 44% over the last twelve months by issuing new shares. That means its earnings are split among a greater number of shares. To celebrate net income while ignoring dilution is like rejoicing because you have a single slice of a larger pizza, but ignoring the fact that the pizza is now cut into many more slices. Check out Compass' historical EPS growth by clicking on this link. Compass was losing money three years ago. And even focusing only on the last twelve months, we don't have a meaningful growth rate because it made a loss a year ago, too. But mathematics aside, it is always good to see when a formerly unprofitable business come good (though we accept profit would have been higher if dilution had not been required). So you can see that the dilution has had a fairly significant impact on shareholders. If Compass' EPS can grow over time then that drastically improves the chances of the share price moving in the same direction. But on the other hand, we'd be far less excited to learn profit (but not EPS) was improving. For the ordinary retail shareholder, EPS is a great measure to check your hypothetical "share" of the company's profit. That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates. On top of the dilution, we should also consider the US$224m impact of unusual items in the last year, which had the effect of suppressing profit. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's hardly a surprise given these line items are considered unusual. Compass took a rather...

Compass delivered a strong first quarter, with management attributing the performance to rapid integration of the acquired Anywhere business and substantial early progress on cost synergies. CEO Robert Reffkin highlighted that over $250 million in cost synergies were actioned within just 82 days of closing the acquisition, surpassing initial expectations. Additionally, leadership pointed to robust transaction growth across brands like Sotheby’s International Realty and Coldwell Banker, and momentum in mortgage and title services as key contributors. Reffkin also noted that the company's new partnership with Rocket Mortgage and Redfin has already begun generating incremental leads and higher engagement for agents. Is now the time to buy COMP? Find out in our full research report (it’s free). Revenue: $2.70 billion vs analyst estimates of $2.67 billion (99.4% year-on-year growth, 1.2% beat) Adjusted EPS: $0.32 vs analyst estimates of -$0.11 (significant beat) Adjusted EBITDA: $61 million vs analyst estimates of $26.66 million (2.3% margin, significant beat) Revenue Guidance for Q2 CY2026 is $4.1 billion at the midpoint, above analyst estimates of $3.96 billion EBITDA guidance for Q2 CY2026 is $330 million at the midpoint, above analyst estimates of $306.6 million Operating Margin: -13%, down from -4% in the same quarter last year Transactions: up 50,383 year on year Market Capitalization: $6.55 billion While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Jason Helfstein (Oppenheimer) asked about the timing and expected adoption rate for the Compass technology rollout to Anywhere’s agents. CEO Robert Reffkin detailed that owned brokerages will have access by early September, with franchise affiliates to follow by spring, and expects strong adoption due to platform flexibility. Dae Lee (JPMorgan) questioned the benefits and challenges of managing multiple brands. Reffkin explained that maintaining distinct brands meets diverse agent needs and that the technology platform is being designed for brand-agnostic functionality. Ryan McKeveny (Zelman) focused on the drivers behind the increased cost synergy target. CFO Scott Wahler...

Image source: The Motley Fool. Wednesday, May 13, 2026 at 8 a.m. ET Chief Executive Officer — Kabir Nath Chief Commercial Officer — Lori Englebert Senior Vice President, Patient Access & Medical Affairs — Steve Levine Senior Vice President, Commercial Operations — Stephen Schultz Need a quote from a Motley Fool analyst? Email [email protected] Kabir Nath: Thank you, Steve, and thank you all for joining us today. It has been a very exciting and productive quarter for COMPASS. The company continues to lead the way in psychedelic science, validated by the confirmation of a rolling NDA submission and review and the award of a Commissioner's National Priority Voucher, or CNPV. With our 005 and 006 data announcement in February, we have delivered positive data from both our Phase III studies. COMP360 has therefore demonstrated what no approved drug for TRD offers, clinically meaningful efficacy with both rapid onset and extended durability. In fact, these extraordinary results redefine rapidity and durability for TRD patients. With only 1 drug approved and actually used for TRD today, we are confident that COMP360 with its differentiated and compelling profile will be an important option for the millions of patients that have been failed by the many approved treatments for MDD. After we announced results of our first positive Phase III trial last year, and based on discussions with the FDA, we began preparing for a potential accelerated launch. As we've said before, we will be launch ready by the end of this year. We've aligned with the FDA on our rolling submission and review plan and have begun submitting modules for the COMP360 NDA. We will continue to submit additional modules on a rolling basis over the coming months. Part B data from 006, which we continue to expect in early Q3, will be the final data set to complete the submission. Given the award of the CNPV, we are already working closely with the FDA to enable as much efficiency and acceleration as possible. In addition, based on the executive order, we are accelerating our engagement with the DEA since there is the potential for federal rescheduling to be completed sooner than the current statutory 90 days post FDA approval. Our 2 large Phase III trials blinded to an unprecedented 26 weeks for psychiatry trials, supported by our large Phase IIb trial, has resulted in over 1,000 patients in the program. With c...

Shares of Compass Pathways (NASDAQ:CMPS) climbed nearly 8% in premarket trading on Wednesday after the company reported first-quarter results that exceeded analyst expectations and highlighted important regulatory advances for its COMP360 psilocybin-based treatment. Compass Pathways posted adjusted earnings per share of -$0.30 for the quarter, beating analyst forecasts of -$0.43 per share. The company continues progressing toward regulatory approval for COMP360, its investigational treatment for treatment-resistant depression. Compass said the U.S. Food and Drug Administration granted the company permission for a rolling New Drug Application submission and review process following positive Phase 3 trial data. The company also received a Commissioner’s National Priority Review Voucher, which could shorten the FDA review timeline to approximately one to two months after filing. Research and development expenses fell to $26.5 million during the three months ended March 31, 2026, compared with $30.9 million in the same period a year earlier. Compass said the reduction reflected lower clinical trial costs as its Phase 3 programme approaches completion. General and administrative expenses also declined to $16.4 million from $18.7 million last year, primarily because of reduced legal and professional service expenses. The company reported net income of $91.2 million, equivalent to $0.71 per basic share and -$0.30 per diluted share. In the same period last year, Compass reported a net loss of $17.9 million. The improvement was mainly driven by a non-cash fair value adjustment gain of $130.9 million related to warrants. “COMP360 represents a fundamentally different approach for patients with treatment resistant depression, unlike any other treatment approved today,” said Kabir Nath, chief executive officer of Compass Pathways. Cash and cash equivalents totaled $466.0 million as of March 31, 2026, compared with $149.6 million at the end of 2025. The increase followed successful financing transactions and warrant exercises completed by the company. Compass said its current cash position is expected to support operations into 2028, extending well beyond the company’s anticipated commercial launch timeline. The company remains on schedule to complete its final NDA submission during the fourth quarter of 2026 and expects to be commercially launch-ready before year-end. Co...

It's been a pretty great week for Compass, Inc. (NYSE:COMP) shareholders, with its shares surging 15% to US$8.74 in the week since its latest first-quarter results. Although revenues of US$2.7b were in line with analyst expectations, Compass surprised on the earnings front, with an unexpected (statutory) profit of US$0.03 per share a nice improvement on the losses that the analystsforecast. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Following the latest results, Compass' nine analysts are now forecasting revenues of US$14.0b in 2026. This would be a major 68% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to surge 1,536% to US$0.32. Before this earnings report, the analysts had been forecasting revenues of US$13.7b and earnings per share (EPS) of US$0.24 in 2026. There's been a pretty noticeable increase in sentiment, with the analysts upgrading revenues and making a very substantial lift in earnings per share in particular. See our latest analysis for Compass Althoughthe analysts have upgraded their earnings estimates, there was no change to the consensus price target of US$13.17, suggesting that the forecast performance does not have a long term impact on the company's valuation. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Compass, with the most bullish analyst valuing it at US$17.00 and the most bearish at US$9.00 per share. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business. Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. It's clear from the latest estimates that Compass' rate of...

Investors like the look of post-merger Compass. Compass stock opened on Monday at $9.45, up 30 percent from the previous day’s close. It’s the company’s highest stock price open since March. The stock bump followed Compass’ earnings call on Tuesday night, its first as a holding company after its landmark deal for Anywhere Real Estate, which brought on brands like Corcoran, Coldwell Banker and Century 21. Part of the surge can be attributed to Compass outperforming analyst expectations for the quarter on both top-line and bottom-line growth. The firm reported a surprise profit of $22 million when analysts were expecting a small loss for the quarter, driven by a non-cash tax benefit of $401 million. Its revenue of $2.7 billion also beat analysts’ estimate of $2.67 billion for the quarter. Compass also reported adjusted EBITDA of $61 million, nearly doubling its projection for the quarter. But it may have been Compass’ efforts to find cost-cutting opportunities that have most excited investors. The brokerage said it now expects to realize $200 million in cost savings in 2026, up from its initial projection of $100 million. The new projections were the “primary driver” for raising EBITDA estimates for 2026 by over $80 million, Needham analyst Bernie McTernan wrote in an analyst report. CEO Robert Reffkin also touched on some of the company’s recent initiatives around listing access, like its partnership with Redfin and Midwest Real Estate Data, the Chicago area’s Multiple Listing Service operator. In February, Compass announced a three-year partnership with Redfin in which the portal would display the brokerage’s “Coming Soon” listings. In the following weeks, a number of copycat partnerships emerged between Zillow and dozens of brokerages, as well as eXp Realty and Realtor.com and Homes.com. (Zillow and Realtor.com announced this week they would syndicate “Coming Soon” listings to each other.) Reffkin took pains to differentiate Compass and Redfin’s agreement, saying that all leads go to the listing agent and listing agents are allowed to do showings. He also emphasized that the partnership enables agents to offer buyers 1 percent off on their mortgage. Reffkin also spoke about its deal with MRED, which has started positioning itself as a national Multiple Listing Service. In April, Compass announced it would be syndicating its “Private Exclusive” and “Coming S...

Compass Minerals (CMP) came out with quarterly earnings of $0.63 per share, missing the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.63 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -5.18%. A quarter ago, it was expected that this minerals producer would post earnings of $0.11 per share when it actually produced earnings of $0.43, delivering a surprise of +290.91%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Compass, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $453.2 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 10.03%. This compares to year-ago revenues of $494.6 million. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Compass shares have added about 34.7% since the beginning of the year versus the S&P 500's gain of 6%. While Compass has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Compass was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) sto...

OVERLAND PARK, Kan. (AP) — OVERLAND PARK, Kan. (AP) — Compass Minerals International Inc. (CMP) on Wednesday reported net income of $12.7 million in its fiscal second quarter. On a per-share basis, the Overland Park, Kansas-based company said it had profit of 30 cents. Earnings, adjusted for non-recurring costs, were 63 cents per share. The minerals producer posted revenue of $453.2 million in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CMP at https://www.zacks.com/ap/CMP

Compass is out of its growth era. First-quarter earnings reported by Compass International Holdings showed the firm contracted in some areas and turned to cost savings as it embarked on its first months after its blockbuster deal for Anywhere Real Estate. The results marked the first full-quarter earnings after the deal combined the firms, and were skewed by a near doubling of revenue to $2.7 billion compared to the first quarter of last year. Its $22 million net income included a non-cash tax benefit of $401 million and $183 million in expenses related to the $1.6 billion deal. Pro forma results, which account for the size of both companies before the merger, reported by the firm showed more muted results after a year of Compass posting double-digit revenue growth. Its pro forma revenue grew 7 percent and its pro forma transaction count grew 2.6 percent, which still outpaced the market by over two percentage points. Compass reported $61 million in adjusted EBITDA and ended the quarter with $484 million in cash and no balance on its revolver. Its total debt at the end of the quarter was $3.14 billion. Compass also reported free cash flow of $168 million. On a pro forma basis, transactions from its franchise network were roughly flat. Franchise royalties per side were down 5 percent year over year to $438. Its title and escrow transactions were up over 13 percent annually to 31,698. The company said it exceeded expectations with its cost-saving efforts, and now projects to realize $200 million in cost synergies for the year, doubling its previous estimate. The company also reported losing agents on a pro forma basis. It was down to 84,187 at the end of the first quarter from 85,724 agents at the end of the fourth quarter for a retention rate of 94 percent. Compass said over half of the more than 5,000 departing agents did not report any gross commission income in the last 12 months, and that its retention rate excluding that cohort was 98 percent. The firm is projecting $4 billion to $4.2 billion in revenue for the second quarter and an adjusted EBITDA of $310 million to $350 million. The firm said it expects to be free cash flow positive for the year. Compass stock was up almost 17 percent to $8.48 in after-hours trading. Who’s guiding Compass’ new era Compass to syndicate exclusive“Coming Soon” listings on Redfin How Compass’ market share exploded post-merg...

Actioned Over $250 Million in Net Cost Synergies in Q1 Increases 2026 Actioned Cost Synergy Target from $250 Million to $300 Million Increases 2026 Realized Cost Synergy Target from $100 Million to $200 Million Q1 GAAP Net Income of $22 Million; Adjusted EBITDA of $61 Million Q1 Pro forma GTV +7.3% YoY for Brokerage & +4.6% YoY for Franchise NEW YORK, May 5, 2026 /PRNewswire/ -- Compass, Inc. ("Compass" or "the Company") (NYSE: COMP), a global real estate services company with a presence in every major U.S. city and approximately 120 countries and territories, announced its financial results for the first quarter ended March 31, 2026. "We achieved strong financial and operational results in our first quarter as a newly combined company. Revenue came in above the mid-point of our guide and Adjusted EBITDA1 came in above the high-end of our guidance range driven by continued OPEX2 discipline and healthy revenue growth" said Robert Reffkin, Founder and Chief Executive Officer of Compass. Reffkin added, "in Q1, we continued to outperform the industry, with pro forma3 Brokerage transactions up 2.6% year-over-year compared to market transactions up 0.2% year-over-year, reflecting 240 basis points of outperformance, while pro forma3 Brokerage GTV was up 7.3% year-over-year, which compared favorably to market volumes that were up 1.5% year-over-year." Reffkin continued, "During the quarter, the Compass team was manically focused on executing against our integration and cost synergy plan. This focus led to over $250 million in net cost synergies being actioned by April 1st, only 82 days after close, and allowing us to now raise our 2026 realized cost synergy target from $100 million to $200 million. Of the $200 million, we expect to realize approximately $130 million through the P&L and the remaining $70 million as a Capex synergy. We are also increasing our Year 1 target for actioned cost synergies from $250 million to $300 million, and raising our total actioned cost synergy target from $400 million to $500 million over the next three years. Approximately $420 million of the $500 million is expected to be realized through the P&L, while the remaining $80 million is expected to be realized as a Capex synergy. By fully realizing these cost synergies, we believe Compass will be able to achieve durable profitability and lower our financial leverage in a flat housing ma...

Image source: The Motley Fool. Tuesday, May 5, 2026 at 5:00 p.m. ET Founder and Chief Executive Officer — Robert Reffkin Chief Financial Officer — Scott Wahlers Head of Investor Relations — Soham Bhonsle Need a quote from a Motley Fool analyst? Email [email protected] Soham Bhonsle: Thank you very much, operator, and good afternoon, everybody, and thank you for joining the Compass First Quarter 2026 Earnings Call. Joining us today will be Robert Reffkin, our Founder and CEO; and Scott Wahlers, our Chief Financial Officer. In discussing our company's performance, we will refer to some non-GAAP measures. You can find a reconciliation of these non-GAAP measures to the most directly comparable GAAP measures in our first quarter 2026 earnings release posted on our Investor Relations website. Additionally, note that since the financial results from the Anywhere transaction are not included in the prior year period or the first 8 days of Q1 2026, the current year and prior year results are not comparable. We have provided supplemental information included in the Form 8-K filed today that presents our revenue and commissions expenses and key business metrics on a pro forma basis as though the businesses were combined from the beginning of 2025. We believe this additional information will be useful to investors to assist in comparing the periods prior and subsequent to the closing of the Anywhere transaction. We will also be making forward-looking statements that are based on our current expectations, forecasts and assumptions and involve risks and uncertainties. These statements include our guidance for the second quarter of 2026 and full year 2026 and comments related to our expectations for realizing cost synergies and operational achievements. Our actual results may differ materially from these statements. You can find more information about risks, uncertainties and other factors that could affect our actual results may differ materially from these statements. You can find more information about risks, uncertainties and other factors that could affect our results in our most recent annual report on Form 10-K filed with the SEC and available on our Investor Relations website. You should not place undue reliance on any forward-looking statements. All information in this presentation is as of today's date, May 5. We expressly disclaim any obligation to update this informa...

Compass (COMP) reported Q1 earnings late Tuesday of $0.03 per diluted share, swinging from a loss of